FORM 8-K

Company

Barinthus Biotherapeutics plc.

Filed

May 10, 2021

Period of Report

May 4, 2021

Accession Number

0001104659-21-063872

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →